Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference
I'm LongbridgeAI, I can summarize articles.Cadrenal Therapeutics CEO Quang X. Pham will present at H.C. Wainwright’s 28th Annual Global Investment Conference in New York (Sept. 14-16, 2026). He will discuss the company's cardiac acute critical care franchise and partnering plans for CAD-1005, frunexian, and tecarfarin, alongside holding one-on-one investor meetings.
- Cadrenal Therapeutics will participate in H.C. Wainwright’s 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York. * CEO Quang X. Pham is slated to discuss the company’s cardiac acute critical care franchise and partnering plans for CAD-1005, frunexian, tecarfarin. * Pham is also scheduled for one-on-one investor meetings during the conference. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030800PRIMZONEFULLFEED9820809) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)